Eli Lilly and Company (LLY) Lobbying Data
LLY lobbying summary
Eli Lilly & Company (LLY) has reported $76.5M in federal lobbying spending across 258 Senate LDA filings since 2020. Its most frequent lobbying issues are Health Issues, Medicare/Medicaid, Trade, Pharmacy. Lobbying firms used include Eli Lilly and Company, Williams and Jensen, Pllc, Tarplin, Downs & Young, LLC.
Lobbying spending by year
| Year | Reported spend |
|---|---|
| 2026 | $180K |
| 2025 | $25.2M |
| 2024 | $13.8M |
| 2023 | $11.7M |
| 2022 | $8.4M |
| 2021 | $10.5M |
See insider trading for LLY or the Lobbying Heavyweights strategy.
Source: Senate Lobbying Disclosure Act (LD-2) filings. The current year is partial.